Lipidation of Temporin-1CEb Derivatives as a Tool for Activity Improvement, Pros and Cons of the Approach.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
22 Jun 2021
Historique:
received: 11 05 2021
revised: 16 06 2021
accepted: 17 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 24 7 2021
Statut: epublish

Résumé

The alarming raise of multi-drug resistance among human microbial pathogens makes the development of novel therapeutics a priority task. In contrast to conventional antibiotics, antimicrobial peptides (AMPs), besides evoking a broad spectrum of activity against microorganisms, could offer additional benefits, such as the ability to neutralize toxins, modulate inflammatory response, eradicate bacterial and fungal biofilms or prevent their development. The latter properties are of special interest, as most antibiotics available on the market have limited ability to diffuse through rigid structures of biofilms. Lipidation of AMPs is considered as an effective approach for enhancement of their antimicrobial potential and in vivo stability; however, it could also have undesired impact on selectivity, solubility or the aggregation state of the modified peptides. In the present work, we describe the results of structural modifications of compounds designed based on cationic antimicrobial peptides DK5 and CAR-PEG-DK5, derivatized at their N-terminal part with fatty acids with different lengths of carbon chain. The proposed modifications substantially improved antimicrobial properties of the final compounds and their effectiveness in inhibition of biofilm development as well as eradication of pre-formed 24 h old biofilms of

Identifiants

pubmed: 34206444
pii: ijms22136679
doi: 10.3390/ijms22136679
pmc: PMC8269107
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Antimicrobial Cationic Peptides 0
temporin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Polish National Science Center
ID : 2012/04/S/ST5/00074;2016/23/D/ST5/02234

Références

Antimicrob Agents Chemother. 2015 Jul;59(7):3695-9
pubmed: 25918147
ACS Med Chem Lett. 2012 Sep 04;3(12):980-4
pubmed: 24900420
Oxid Med Cell Longev. 2016;2016:3240261
pubmed: 27822337
Biochem Cell Biol. 2017 Feb;95(1):91-98
pubmed: 28165293
Curr Opin Microbiol. 2016 Oct;33:35-40
pubmed: 27318321
Int J Antimicrob Agents. 2018 Jul;52(1):52-62
pubmed: 29649587
Sci Rep. 2013;3:1678
pubmed: 23588060
J Pept Sci. 2007 Jan;13(1):37-43
pubmed: 17031869
Biophys J. 2011 Jul 6;101(1):100-9
pubmed: 21723819
Front Aging Neurosci. 2010 Mar 18;2:10
pubmed: 20552048
PLoS One. 2009;4(4):e5210
pubmed: 19381294
Chem Biol Drug Des. 2012 May;79(5):653-62
pubmed: 22348663
Langmuir. 2012 Aug 7;28(31):11599-608
pubmed: 22788380
Anal Biochem. 2000 Dec 15;287(2):252-60
pubmed: 11112271
Int J Antimicrob Agents. 2003 Nov;22(5):465-78
pubmed: 14602364
Perspect Medicin Chem. 2014 Aug 28;6:25-64
pubmed: 25232278
Amino Acids. 2012 Jul;43(1):153-63
pubmed: 22143429
Surgery. 1986 Nov;100(5):815-21
pubmed: 3095942
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
Biochem Pharmacol. 2017 Jun 1;133:152-163
pubmed: 27687641
J Cell Biol. 1988 Mar;106(3):761-71
pubmed: 2450098
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Methods Mol Biol. 2013;924:533-65
pubmed: 23034762
PLoS One. 2015 Oct 16;10(10):e0140377
pubmed: 26473368
ChemMedChem. 2009 Jun;4(6):967-75
pubmed: 19301317
Biochemistry. 1998 Mar 17;37(11):3909-16
pubmed: 9521712
Infect Immun. 2015 Oct 26;84(1):241-53
pubmed: 26502911
Nat Rev Immunol. 2016 May;16(5):321-34
pubmed: 27087664
Nat Rev Microbiol. 2005 Mar;3(3):238-50
pubmed: 15703760
Biochim Biophys Acta. 2014 Oct;1838(10):2625-34
pubmed: 24978107
Biochim Biophys Acta. 2016 May;1858(5):1061-9
pubmed: 26724202
Front Cell Infect Microbiol. 2020 Jul 07;10:326
pubmed: 32733816
Biochim Biophys Acta. 2016 May;1858(5):1004-11
pubmed: 26603779
J Phys Chem B. 2007 Jul 12;111(27):7812-24
pubmed: 17569554

Auteurs

Paulina Kosikowska-Adamus (P)

Faculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.

Emilia Sikorska (E)

Faculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.

Dariusz Wyrzykowski (D)

Faculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.

Aleksandra Walewska (A)

Faculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.

Anna Golda (A)

Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Kraków, Poland.

Milena Deptuła (M)

Laboratory of Tissue Engineering and Regenerative Medicine, Department of Embryology, Medical University of Gdansk, 80-210 Gdańsk, Poland.

Michał Obuchowski (M)

Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology UG-MUG, Medical University of Gdansk, 80-210 Gdańsk, Poland.

Adam Prahl (A)

Faculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.

Michał Pikuła (M)

Laboratory of Tissue Engineering and Regenerative Medicine, Department of Embryology, Medical University of Gdansk, 80-210 Gdańsk, Poland.

Adam Lesner (A)

Faculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH